[{"address1": "12278 Scripps Summit Drive", "city": "San Diego", "state": "CA", "zip": "92131", "country": "United States", "phone": "858 875 1800", "website": "https://www.fatetherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bahram  Valamehr M.B.A., Ph.D.", "age": 46, "title": "President & CEO", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 644500, "exercisedValue": 0, "unexercisedValue": 13288}, {"maxAge": 1, "name": "Ms. Cindy R. Tahl J.D.", "age": 51, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 612500, "exercisedValue": 0, "unexercisedValue": 25250}, {"maxAge": 1, "name": "Mr. Victor  Hong", "title": "Vice President of Corporate Development & Finance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Francis", "title": "Vice President Of Human Resources & Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Henry", "age": 60, "title": "Senior Vice President of Clinical Operations", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tunde  Babalola", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yu  Cai", "title": "Head of Intellectual Property & Assistant General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.68, "open": 0.689, "dayLow": 0.6611, "dayHigh": 0.7647, "regularMarketPreviousClose": 0.68, "regularMarketOpen": 0.689, "regularMarketDayLow": 0.6611, "regularMarketDayHigh": 0.7647, "payoutRatio": 0.0, "beta": 2.415, "forwardPE": -0.44815478, "volume": 3604676, "regularMarketVolume": 3604676, "averageVolume": 2308696, "averageVolume10days": 2080580, "averageDailyVolume10Day": 2080580, "bid": 0.5264, "ask": 0.8594, "bidSize": 2, "askSize": 2, "marketCap": 86280080, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 6.98, "priceToSalesTrailing12Months": 6.3296957, "fiftyDayAverage": 1.1152, "twoHundredDayAverage": 2.57455, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -107519600, "profitMargins": 0.0, "floatShares": 99923225, "sharesOutstanding": 114597000, "sharesShort": 14571003, "sharesShortPriorMonth": 13060901, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1271, "heldPercentInsiders": 0.02239, "heldPercentInstitutions": 0.89806, "shortRatio": 4.27, "shortPercentOfFloat": 0.1458, "impliedSharesOutstanding": 114597000, "bookValue": 2.798, "priceToBook": 0.26908505, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -186262000, "trailingEps": -1.64, "forwardEps": -1.68, "enterpriseToRevenue": -7.888, "enterpriseToEbitda": 0.609, "52WeekChange": -0.8882265, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 0.7529, "targetHighPrice": 12.0, "targetLowPrice": 2.5, "targetMeanPrice": 6.38889, "targetMedianPrice": 5.0, "recommendationMean": 2.42857, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 279068000, "totalCashPerShare": 2.435, "ebitda": -176576992, "totalDebt": 85265000, "quickRatio": 7.391, "currentRatio": 7.578, "totalRevenue": 13631000, "debtToEquity": 26.752, "revenuePerShare": 0.12, "returnOnAssets": -0.25812998, "returnOnEquity": -0.54213, "grossProfits": -104900000, "freeCashflow": -60771876, "operatingCashflow": -122874000, "revenueGrowth": 0.11, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -25.274729, "financialCurrency": "USD", "symbol": "FATE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 10.720588, "regularMarketPrice": 0.7529, "fiftyDayAverageChange": -0.36230004, "fiftyDayAverageChangePercent": -0.3248745, "twoHundredDayAverageChange": -1.8216499, "twoHundredDayAverageChangePercent": -0.70756054, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "shortName": "Fate Therapeutics, Inc.", "longName": "Fate Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1380634200000, "postMarketChangePercent": -1.71337, "postMarketPrice": 0.74, "postMarketChange": -0.0129, "regularMarketChange": 0.0729, "regularMarketDayRange": "0.6611 - 0.7647", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2308696, "fiftyTwoWeekLowChange": 0.09289998, "fiftyTwoWeekLowChangePercent": 0.14075753, "fiftyTwoWeekRange": "0.66 - 6.98", "fiftyTwoWeekHighChange": -6.2271, "fiftyTwoWeekHighChangePercent": -0.89213467, "fiftyTwoWeekChangePercent": -88.82265, "earningsTimestamp": 1741208460, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "earningsCallTimestampStart": 1715288400, "earningsCallTimestampEnd": 1715288400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.64, "epsForward": -1.68, "epsCurrentYear": -1.458, "priceEpsCurrentYear": -0.51639235, "corporateActions": [], "postMarketTime": 1743805667, "regularMarketTime": 1743796803, "exchange": "NGM", "messageBoardId": "finmb_39268712", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Fate Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]